Modification and Inhibition of Vancomycin Group Antibiotics by Formaldehyde and Acetaldehyde
Authors:
- Albert J. R. HeckAHAlbert J. R. Heck
- Pauline J. BonniciPBPauline J. Bonnici
- Eefjan BreukinkEBEefjan Breukink
- 16 February 2001
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 7 (4) , 910-916
Abstract
It is shown that several vancomycin group antibiotics (vancomycin, eremomycin, and avoparcin) undergo spontaneous chemical modifications when kept at room temperature at neutral pH in aqueous solutions containing traces of formaldehyde or acetaldehyde. This chemical modification predominantly results in a mass increase of 12 Da in the reaction with formaldehyde and 26 Da in the case of acetaldehyde. By using tandem mass spectrometry the modification can unambiguously be identified as originating from the formation of a ring‐closed 4‐imidazolidinone moiety at the N‐terminus of the glycopeptide antibiotics, that is, near the receptor binding pocket of the glycopeptide antibiotics. Bioaffinity mass spectrometry shows that this ring‐closure results in a dramatically decreased affinity for the peptidoglycan‐mimicking D‐alanyl‐D‐alanine receptor. Additionally, in vitro inhibition measurements on two different strains of bacteria have revealed that the modified antibiotics display reduced antibacterial activity. The ring‐closure is also shown to have a dissociative effect on the dimerization of the vancomycin‐analogue eremomycin. The spontaneous reaction of vancomycin with formaldehyde or acetaldehyde may have implications not only for the clinical use of this class of antibiotics, but also for the effectiveness of these antibiotics when they are used in chiral separation chromatography or capillary electrophoresis.Keywords
This publication has 33 references indexed in Scilit:
- The Formation of Heterodimers by Vancomycin Group AntibioticsChemistry – A European Journal, 2000
- Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacteriumChemistry & Biology, 1999
- Interactions of α- and β-avoparcin with bacterial cell-wall receptor-mimicking peptides studied by electrospray ionization mass spectrometryJournal of Antimicrobial Chemotherapy, 1999
- Chemistry, Biology, and Medicine of the Glycopeptide AntibioticsAngewandte Chemie International Edition, 1999
- An Analysis of the Origins of a Cooperative Binding Energy of DimerizationScience, 1998
- Dimerization of A82846B, Vancomycin and Ristocetin: Influence on Antibiotic Complexation with Cell Wall Model Peptides.The Journal of Antibiotics, 1996
- The glycopeptide story – how to kill the deadly ‘superbugs’Natural Product Reports, 1996
- Glycopeptide Antibiotic Activity and the Possible Role of Dimerization: A Model for Biological SignalingJournal of the American Chemical Society, 1994
- Vancomycin Resistance: Decoding the Molecular LogicScience, 1993
- Avoparcin and epiavoparcinJournal of the American Chemical Society, 1981